Impact of an extrafascial versus intrafascial injection for supraclavicular brachial plexus block on respiratory function: a randomized, controlled, double-blind trial

被引:1
|
作者
Grape, Sina [1 ,2 ]
Kirkham, Kyle [3 ,4 ]
Zemirline, Nadjib [1 ]
Bikfalvi, Alexis [5 ]
Albrecht, Eric [2 ,5 ]
机构
[1] Valais Hosp, Dept Anaesthesia, Sion, Switzerland
[2] Univ Lausanne, Lausanne, Switzerland
[3] Toronto Western Hosp, Dept Anesthesia, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Univ Hosp Lausanne, Dept Anesthesia, Lausanne, Switzerland
关键词
HEMIDIAPHRAGMATIC PARESIS; NERVE DISTANCE;
D O I
10.1136/rapm-2022-103634
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Introduction Hemidiaphragmatic paresis after ultrasound-guided supraclavicular brachial plexus block is reported to occur in up to 67% of patients. We tested the hypothesis that an injection outside the brachial plexus sheath reduces the incidence of hemidiaphragmatic paresis compared with an intrafascial injection while providing similar analgesia. Methods Fifty American Society of Anesthesiologists I-Ill patients scheduled for elective upper limb surgery received a supraclavicular brachial plexus block using 30 mL of 1:1 mixture of mepivacaine 1% and ropivacaine 0.5%. The block procedures were randomized to position the needle tip either within the brachial plexus after piercing the sheath (intrafascial injection) or outside the brachial plexus sheath (extrafascial injection). The primary outcome was the incidence of hemidiaphragmatic paresis 30 min after the injection, measured by M-mode ultrasonography. Additional outcomes included time to surgery readiness, and resting and dynamic pain scores at 24 hours postoperatively (Numeric Rating Scale, 0-10). Results The incidence of hemidiaphragmatic paresis 30 min after the injection was 9% (95% CI 1% to 29%) and 0% (95% CI 0% to 15%) in the intrafascial and extrafascial groups respectively (p=0.14). Extrafascial injection was associated with a longer time to surgery readiness (intrafascial: 18 min (95% CI: 16 to 21 min); extrafascial: 37 min (95% CI: 31 to 42 min); p<0.001). At 24 hours, resting and dynamic pain scores were similar between groups. Discussion Ultrasound-guided supraclavicular brachial plexus block with an extrafascial injection does not reduce the incidence of hemidiaphragmatic paresis although it provides similar analgesia, when compared with an intrafascial injection. The longer time to surgery readiness is less compatible with contemporary operating theater efficiency requirements.
引用
收藏
页码:604 / 609
页数:6
相关论文
共 50 条
  • [1] Extrafascial injection for interscalene brachial plexus block reduces respiratory complications compared with a conventional intrafascial injection: a randomized, controlled, double-blind trial
    Palhais, N.
    Brull, R.
    Kern, C.
    Jacot-Guillarmod, A.
    Charmoy, A.
    Farron, A.
    Albrecht, E.
    BRITISH JOURNAL OF ANAESTHESIA, 2016, 116 (04) : 531 - 537
  • [2] Reduced hemidiaphragmatic paresis with extrafascial compared with conventional intrafascial tip placement for continuous interscalene brachial plexus block: a randomized, controlled, double-blind trial
    Albrecht, E.
    Bathory, I.
    Fournier, N.
    Jacot-Guillarmod, A.
    Farron, A.
    Brull, R.
    BRITISH JOURNAL OF ANAESTHESIA, 2017, 118 (04) : 586 - 592
  • [3] Hemi-diaphragmatic paresis following extrafascial versus conventional intrafascial approach for interscalene brachial plexus block: A double-blind randomised, controlled trial
    Ayyanagouda, Basavaraja
    Hosalli, Vinod
    Kaur, Prableen
    Ambi, Uday
    Hulkund, S. Y.
    INDIAN JOURNAL OF ANAESTHESIA, 2019, 63 (05) : 375 - 381
  • [4] Extrafascial injection for interscalene block reduces respiratory complications compared to a subfascial injection: a randomized, controlled, double-blind trial
    Palhais, Nuno
    Brull, Richard
    Kern, Christian
    Jacot-Guillarmod, Alain
    Charmoy, Alexia
    Bathory, Istvan
    Farron, Alain
    Albrecht, Eric
    SWISS MEDICAL WEEKLY, 2015, 145 : 4S - 5S
  • [5] Extrafascial catheter tip placement for continuous interscalene brachial plexus block reduces hemidiaphragmatic paresis compared with a conventional intrafascial tip placement: a randomized controlled, double-blind trial
    Eric, Albrecht
    Nicolas, Fournier
    Alain, Farron
    Istvan, Bathory
    SWISS MEDICAL WEEKLY, 2017, 147 : 3S - 3S
  • [6] Respiratory impact of local anaesthetic volume after interscalene brachial plexus block with extrafascial injection: a randomised controlled double-blinded trial
    Renard, Yves
    Grape, Sina
    Gonvers, Erin
    Rossel, Jean-Benoit
    Goetti, Patrick
    Albrecht, Eric
    BRITISH JOURNAL OF ANAESTHESIA, 2025, 134 (04) : 1153 - 1160
  • [7] Magnesium sulfate versus clonidine as an adjuvant to ultrasound-guided supraclavicular brachial plexus block in upper limb surgery: A double-blind randomized controlled trial
    Mohanakumar, Archana
    Thangavelu, Ramyavel
    Paul, Anju Annie
    Ranjan, R., V
    George, Sagiev Koshy
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2020, 11 (03) : 107 - 112
  • [8] Efficacy and safety of extrafascial injection versus intrafascial injection for interscalene brachial plexus block: a systematic review and meta-analysis
    Sharapi, Mahfouz
    Yassin, Mazen
    Arafeh, Yusra
    Afifi, Eslam
    El-samahy, Mohamed
    Thomas, Jubil
    MINERVA ANESTESIOLOGICA, 2024, 90 (06)
  • [9] Randomized Comparison of Extrafascial Versus Subfascial Injection of Local Anesthetic During Ultrasound-Guided Supraclavicular Brachial Plexus Block
    Sivashanmugam, T.
    Ray, Suja
    Ravishankar, M.
    Jaya, V.
    Selvam, E.
    Karmakar, Manoj Kumar
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2015, 40 (04) : 337 - 343
  • [10] Effect of dexmedetomidine on characteristics of ultrasound-guided supraclavicular brachial plexus block with levobupivacaine-A prospective double-blind randomized controlled trial
    Reddy, Bhumireddy Suneel
    Gaude, Yogesh K.
    Vaidya, Shriram
    Kini, Gurudas K.
    Budania, Lokvendra S.
    Eeshwar, M., V
    JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2021, 37 (03) : 371 - 377